Stempeutics to introduce new stem cell products by 2014
According to the company, the products are likely to complete their phase III trials by early 2014, facilitating the launch, news.in.msn.com reports. The Phase II trials are expected
Biointron Biological has launched RushData, a new platform to support the process of antibody discovery for pharmaceutical and biotechnology companies employing AI and machine learning (ML).
The approval has been confirmed for the UK, Belgium, Finland, Ireland, Luxemburg, Netherlands and Sweden. Octapharma’s manufacturing process for OctaplasLG, which is a solvent/detergent treated, prion-reduced, plasma product